MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-23-0012841
Schon Pharmaceuticals Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹35.42 Cr
▲ 7% YoY
Net profit · FY 2024
₹57.12 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹2.13 Cr
EBITDA margin 6%
Authorised capital
₹1.25 Cr
Registered with MCA
Paid-up capital
₹1.23 Cr
Issued & subscribed
Open charges
₹30.46 Cr
Satisfied ₹20.65 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
77
Provident fund records
About Schon Pharmaceuticals Limited
Data last updated:
Schon Pharmaceuticals Limited is a public limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24231MP1994PLC007829. Its GSTIN is 23AAFCS6596K1ZT (Madhya Pradesh).
The company has an authorised share capital of ₹1.25 Cr and a paid-up capital of ₹1.23 Cr. It was formerly known as Schon Pharmaceuticals Private Limited. It is led by directors including Anil Bhatia and Sunil Bhatia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 145/2 – A – B Jambudi Hapsi Hatod Road, Indore, Madhya Pradesh, India – 453112.
As per the financials filed for FY 2024, the company reported a revenue of ₹35.42 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹57.12 Lakh (net margin 1.6%) and EBITDA of ₹2.13 Cr (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 16% over five years.
The company has about 77 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Schon Pharmaceuticals. As per MCA filings, the company has open charges of ₹30.46 Cr and satisfied charges of ₹20.65 Cr on record. Court records list 10 cases involving the company, including 2 filed by the company and 6 filed against it; 1 case is pending.
Schon Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0012841). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website schonpharma.in.
Company Details of Schon Pharmaceuticals Limited
CIN U24231MP1994PLC007829
Registration Number 007829
Incorporation Date 30 September 1994
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-23-0012841
CIN History of Schon Pharmaceuticals Limited
Schon Pharmaceuticals has one previous CIN (Corporate Identification Number): L24231MP1994PLC007829. The current CIN is U24231MP1994PLC007829, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231MP1994PLC007829 | Current |
| L24231MP1994PLC007829 | Previous |
Recognitions & Rankings of Schon Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address145/2 – A – B Jambudi Hapsi Hatod Road, Indore, Madhya Pradesh, India – 453112
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Schon Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Schon Pharmaceuticals Limited
Schon Pharmaceuticals operates one associated brand: Schon Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of syrup, capsules, tablets, injecatables and ointment | schonpharma.in |
Business Activity of Schon Pharmaceuticals Limited
The main business activity of Schon Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Schon Pharmaceuticals Limited FY 2025 filings available
Schon Pharmaceuticals Limited reported revenue of ₹35.42 Cr (up 7% YoY) for FY 2024.
Revenue · FY 2024
₹35.42 Cr ▲ 7%
Net profit · FY 2024
₹57.12 Lakh margin 1.6%
EBITDA · FY 2024
₹2.13 Cr margin 6%
Compounded Annual Growth Rate (CAGR) of Schon Pharmaceuticals Limited
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 11%
5 years · compounded
▲ 16%
EBITDA CAGR growth
3 years · compounded
▲ 2%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 7% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Schon Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹35.42 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.13 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹57.12 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Schon Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Schon Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Schon Pharmaceuticals Limited
Schon Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Bhatia | Director | 30 Sep 1994 | 32 Years 0 Months | Current |
| Sunil Bhatia | Director | 30 Sep 1994 | 32 Years 0 Months | Current |
| Pooja Bhatia | Director | 28 Aug 2023 | 3 Years 1 Months | Current |
| Prashant Singh | Director | 01 Apr 2014 | 12 Years 6 Months | Current |
Peer Comparison of Schon Pharmaceuticals Limited
Schon Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmaceuticals Export Promotion Council of India | ₹35.95 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Hyderabad, Telangana, India |
| Salas Pharmaceuticals Private Limited | ₹35.84 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Patna, Bihar, India |
| Radicura Pharmaceuticals Private Limited | ₹35.79 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | New Delhi, Delhi, India |
| Vetindia Pharmaceuticals Limited | ₹35.78 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Telangana, India |
| A N Pharmaceuticals Private Limited | ₹35.77 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | New Delhi, Delhi, India |
| Schon Pharmaceuticals Limited this company | ₹35.42 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Indore, Madhya Pradesh, India |
| Evolet Pharmaceuticals Private Limited | ₹35.41 Cr (FY 2025) | •••• | •••• | -34.0% | •••• | Bhorakalan, Haryana, India |
| CSC Pharmaceuticals Private Limited | ₹35.18 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Panchkula, Haryana, India |
| Jawa Pharmaceuticals (India) Pvt. Ltd | ₹35.04 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Rajasthan, India |
| Afflatus Pharmaceuticals Private Limited | ₹35.04 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | New Dldehi, Delhi, India |
| Wiscon Pharmaceuticals Private Limited | ₹34.98 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Schon Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Schon Pharmaceuticals Limited
Schon Pharmaceuticals Limited is audited by M. K. Shah & Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M. K. Shah & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Schon Pharmaceuticals Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Schon Pharmaceuticals Limited
Open charges
₹30.46 Cr
Satisfied charges
₹20.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2025 | Sidbi | ₹1.1 Cr | Open |
| 23 Jan 2024 | Sidbi | ₹3.96 Cr | Open |
| 11 Jan 2022 | Sidbi | ₹2 Cr | Open |
| 26 Oct 2018 | Axis Bank Limited | ₹23.4 Cr | Open |
| 19 Nov 2015 | Kotak Mahindra Bank Limited | ₹8 Cr | Satisfied |
Total charge records: 12 View all charges
Legal Cases of Schon Pharmaceuticals Limited
Schon Pharmaceuticals Limited has 10 court cases on record: 2 filed by Schon Pharmaceuticals, 6 filed against it, 2 where it is another party. 1 case is pending and 9 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Total cases
10
Filed by the company
2
Filed against the company
6
Pending
1
Disposed
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 5 | 1 |
| High courts | 2 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West Godavari, Andhra Pradesh | Criminal complaint | Filed against the company by State Director of A.P | Pending |
| District court, Indore, Madhya Pradesh | Court case (RCS B) | Filed by the company against Aakash Pharma Tech | Disposed |
| District court, Ahmedabad, Gujarat | Court case (SMST R) | Filed against the company by an individual | Disposed |
| District court, East Godavari, Andhra Pradesh | Criminal complaint | Filed against the company by an individual | Disposed |
| District court, Ratnagiri, Maharashtra | Court case (Cri.Rev.App.) | Company is another party | Disposed |
Premium access
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Schon Pharmaceuticals Limited
Schon Pharmaceuticals Limited has 4 MSME Form 1 returns on record between 2016 and 2019, listing 53 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Flexi Caps & Polymers Private Limited | •••• | •••• | •••• |
| Doer Packaging Private Limited | •••• | •••• | •••• |
| Tpac Packaging India Pvt. Ltd. | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Vision Pharmacoat Private Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 4 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Schon Pharmaceuticals Limited
Schon Pharmaceuticals Limited has a workforce of 77 employees as of Mar 26, 2025.
Employee count
77
Active EPFO establishments
1
Employee growth
5.48%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Schon Pharmaceuticals Limited
Schon Pharmaceuticals Limited has 7 board changes on record since 1994: 5 appointments and 2 cessations. The latest: Pooja Bhatia ceased to be Additional Director on 29 Sep 2023.
Charges
A charge with Axis Bank Limited of Rs. 23.40 Cr registered on 26 Oct 2018 with Charge ID 100220359 was modified on 14 Oct 2025.
AGM
Schon Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Schon Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Sidbi amounted to Rs. 1.10 Cr with Charge ID 101060896 was registered on 28 Feb 2025.
Charges
A charge with Sidbi amounted to Rs. 3.96 Cr with Charge ID 100853535 was registered on 23 Jan 2024.
Ceased
Pooja Bhatia ceased to be Additional Director.
Appointed
Pooja Bhatia was appointed as Director.
Charges
A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 100521353 was registered on 11 Jan 2022.
Charges
A charge registered on 19 Nov 2015 via Charge ID 10612358 with Kotak Mahindra Bank Limited was fully satisfied on 01 Jan 2019.
Charges
A charge with Axis Bank Limited amounted to Rs. 23.40 Cr with Charge ID 100220359 was registered on 26 Oct 2018.
Charges
A charge registered on 28 Mar 2014 via Charge ID 10488103 with Idbi Bank Limited was fully satisfied on 12 Feb 2016.
Charges
A charge registered on 13 Jun 2007 via Charge ID 10061162 with Bank Of Baroda was fully satisfied on 25 Jan 2016.
24 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Schon Pharmaceuticals Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Schon Pharmaceuticals Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Schon Pharmaceuticals Limited
Schon Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAFCS6596K1ZT | Madhya Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Schon Pharmaceuticals Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Schon Pharmaceuticals Limited
Schon Pharmaceuticals is an active public limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 1994 (32+ years old) and is registered under CIN U24231MP1994PLC007829.
Schon Pharmaceuticals reported revenue of ₹35.42 Cr for FY 2024 (up 7% YoY).
Schon Pharmaceuticals has 4 current directors:
- Anil Bhatia - Director
- Sunil Bhatia - Director
- Pooja Bhatia - Director
- Prashant Singh - Director
Schon Pharmaceuticals reported a net profit of ₹57.12 Lakh (net margin 1.6%) and EBITDA of ₹2.13 Cr (EBITDA margin 6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Schon Pharmaceuticals is 11% over three years and 16% over five years. In the latest year (FY 2024) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Schon Pharmaceuticals is 23AAFCS6596K1ZT, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Schon Pharmaceuticals is U24231MP1994PLC007829. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Schon Pharmaceuticals has 10 court cases on record: 2 filed by the company and 6 filed against it. 1 is pending. Most are in the district courts.
Schon Pharmaceuticals was incorporated on 30 September 1994, making it 32+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Schon Pharmaceuticals by revenue are Pharmaceuticals Export Promotion Council of India, Salas Pharmaceuticals Private Limited, Radicura Pharmaceuticals Private Limited, Vetindia Pharmaceuticals Limited, A N Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Pooja Bhatia ceased to be Additional Director on 29 Sep 2023. Pooja Bhatia was appointed as Director on 28 Aug 2023. Prashant Singh was appointed as Director on 01 Apr 2014. Schon Pharmaceuticals has 7 board changes on record in total.
Yes, Schon Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0012841).